Marburg virus outbreak in Rwanda traced to Bats
On Nov. 1, 2024, the World Health Organization reported that as of October 31, 66 confirmed cases, including…
On Nov. 1, 2024, the World Health Organization reported that as of October 31, 66 confirmed cases, including…
On Oct. 25, 2024, the World Health Organization reported that as of October 24, a total of 64…
On Oct. 14, 2024, the Global Preparedness Monitoring Board (GPMB) released a report that outlined 15 key drivers…
On Oct. 11, 2024, the World Health Organization (WHO) reported that a total of 58 cases of Marburg…
On Sept. 28, 2024, the World Health Organization (WHO) announced that Rwandan health authorities were intensifying outbreak control…
On Jun. 2, 2023, the Ministry of Health of the United Republic of Tanzania declared the end of…
On Apr. 15, 2023, the World Health Organization (WHO) announced that six additional laboratory-confirmed cases of Marburg virus…
On Mar. 21, 2023, the Ministry of Health of the United Republic of Tanzania declared an outbreak of…
On Feb. 13, 2023, Equatorial Guinea today confirmed its first-ever outbreak of Marburg virus disease. Preliminary tests carried…
On Jul. 17, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
On Jul. 7, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
On Feb. 16, 2022, BioNTech announced it had introduced its approach to establishing scalable vaccine production by developing…
On Sept. 15, 2021, Guinea declared the end of the Marburg virus disease outbreak having recorded no new…
On Aug. 9, 2021, health authorities in Guinea confirmed a case of Marburg virus disease in the southern…
On Mar. 26, 2021, BioNTech announced that the European Medicines Agency (EMA) approved the manufacturing of the COVID-19…
On Feb. 10, 2021, BioNTech announced they had increased their manufacturing capacity in Marburg, Germany to up to…
On Sept. 17, 2020, BioNTech announced an agreement with Novartis to acquire their GMP certified manufacturing facility in…
On Sept. 15, 2020, Soligenix announced publication of nonclinical results characterizing filovirus protein antigens (including for Ebola and…
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
In 1978, the U.S. Centers for Disease Control and Prevention (CDC) completed construction of a new hot lab…
In 1969, the U.S. Centers for Disease Control and Prevention (CDC) opened its first permanent high-containment laboratory (HCL)…